South Korea's AI Initiatives and ATDC Startups Secure FDA Breakthrough Status

South Korea is increasing its activity in the artificial intelligence space with new initiatives, according to TechAnnouncer.

Two Advanced Technology Development Center (ATDC) health technology startups, Nephrodite and OrthoPreserve, have received the FDA's Breakthrough Devices designation, a rare achievement impacting roughly 40% of applicants (ATDC). Nephrodite is innovating continuous artificial kidney technology, addressing a chronic kidney disease market that costs Medicare $124.5 billion annually, according to the Centers for Disease Control and Prevention. OrthoPreserve is developing a minimally invasive meniscus implant, targeting the 25% of the million patients annually who undergo meniscus surgery and still experience recurring knee pain (ATDC).

Ryla.ai has launched its AI Influencer Generator platform, setting a new standard in content creation per ACCESS Newswire on March 20, 2026.

The Texas Symposium on Machine Learning, Responsible AI, and Robotics explored the future of intelligent systems and ethical innovation, reports UT Austin News.

Midsized freight brokers can benefit from Transportation Management Systems (TMS) to enhance operational efficiency and customer relationship management in a competitive landscape, according to TechBullion.

The International Association of Privacy Professionals is offering resources to navigate the evolving landscape of AI governance, reports TechAnnouncer.

Sources:

• Techannouncer

• Georgia Institute Of Technology

• Techannouncer

• The University Of Texas At Austin

• Techbullion

• Finanznachrichten.de